» Articles » PMID: 28442607

-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection

Abstract

Zika virus (ZIKV) infection is a global health emergency that causes significant neurodegeneration. Neurodegenerative processes may be exacerbated by -methyl-d-aspartate receptor (NMDAR)-dependent neuronal excitoxicity. Here, we have exploited the hypothesis that ZIKV-induced neurodegeneration can be rescued by blocking NMDA overstimulation with memantine. Our results show that ZIKV actively replicates in primary neurons and that virus replication is directly associated with massive neuronal cell death. Interestingly, treatment with memantine or other NMDAR blockers, including dizocilpine (MK-801), agmatine sulfate, or ifenprodil, prevents neuronal death without interfering with the ability of ZIKV to replicate in these cells. Moreover, experiments demonstrate that therapeutic memantine treatment prevents the increase of intraocular pressure (IOP) induced by infection and massively reduces neurodegeneration and microgliosis in the brain of infected mice. Our results indicate that the blockade of NMDARs by memantine provides potent neuroprotective effects against ZIKV-induced neuronal damage, suggesting it could be a viable treatment for patients at risk for ZIKV infection-induced neurodegeneration. Zika virus (ZIKV) infection is a global health emergency associated with serious neurological complications, including microcephaly and Guillain-Barré syndrome. Infection of experimental animals with ZIKV causes significant neuronal damage and microgliosis. Treatment with drugs that block NMDARs prevented neuronal damage both and These results suggest that overactivation of NMDARs contributes significantly to the neuronal damage induced by ZIKV infection, and this is amenable to inhibition by drug treatment.

Citing Articles

The kinase RIPK3 promotes neuronal survival by suppressing excitatory neurotransmission during central nervous system viral infection.

Estevez I, Buckley B, Lindman M, Panzera N, Chou T, McCourt M Immunity. 2025; 58(3):666-682.e6.

PMID: 39999836 PMC: 11903149. DOI: 10.1016/j.immuni.2025.01.017.


Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches.

Khan A, Zakirullah , Wahab S, Hong S Virol J. 2025; 22(1):26.

PMID: 39905499 PMC: 11792744. DOI: 10.1186/s12985-025-02622-z.


An Overview of Zika Virus and Zika Virus Induced Neuropathies.

Wahaab A, Mustafa B, Hameed M, Batool H, Tran Nguyen Minh H, Tawaab A Int J Mol Sci. 2025; 26(1.

PMID: 39795906 PMC: 11719530. DOI: 10.3390/ijms26010047.


A zebrafish-based in vivo model of Zika virus infection unveils alterations of the glutamatergic neuronal development and NS4A as a key viral determinant of neuropathogenesis.

Sow A, Jamadagni P, Scaturro P, Patten S, Chatel-Chaix L PLoS Pathog. 2024; 20(12):e1012756.

PMID: 39621753 PMC: 11637437. DOI: 10.1371/journal.ppat.1012756.


The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection.

Klohn M, Gomer A, He Q, Brown R, Todt D, Wang L Antimicrob Agents Chemother. 2024; 68(11):e0103524.

PMID: 39360823 PMC: 11539220. DOI: 10.1128/aac.01035-24.


References
1.
Brasil P, Carvalho Sequeira P, dAvila Freitas A, Zogbi H, Amaral Calvet G, de Souza R . Guillain-Barré syndrome associated with Zika virus infection. Lancet. 2016; 387(10026):1482. DOI: 10.1016/S0140-6736(16)30058-7. View

2.
DiFiglia M . Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 1990; 13(7):286-9. DOI: 10.1016/0166-2236(90)90111-m. View

3.
Cao-Lormeau V, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J . Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016; 387(10027):1531-1539. PMC: 5444521. DOI: 10.1016/S0140-6736(16)00562-6. View

4.
Tappe D, Perez-Giron J, Zammarchi L, Rissland J, Ferreira D, Jaenisch T . Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol. 2015; 205(3):269-73. PMC: 4867002. DOI: 10.1007/s00430-015-0445-7. View

5.
Hoffmann H, Gremme T, Hatt H, Gottmann K . Synaptic activity-dependent developmental regulation of NMDA receptor subunit expression in cultured neocortical neurons. J Neurochem. 2000; 75(4):1590-9. DOI: 10.1046/j.1471-4159.2000.0751590.x. View